STOCK TITAN

DGX (NYSE: DGX) Form 144: planned sale of vested common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

DGX filed a Form 144 indicating planned sales of common stock following restricted stock vesting. The notice lists 480 shares with a 02/12/2026 date and 631 shares with a 02/14/2026 date, with transactions routed through Fidelity Brokerage Services LLC.

Positive

  • None.

Negative

  • None.

Insights

Planned sales tied to vested awards are administrative and routine.

The filing lists common shares associated with restricted stock vesting dated 02/12/2026 (480 shares) and 02/14/2026 (631 shares), processed through Fidelity Brokerage Services LLC.

These entries reflect forthcoming dispositions by holders; timing and final execution depend on holder decisions and brokerage handling. Subsequent filings would confirm actual sales and proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does DGX's Form 144 disclose about share amounts?

The Form 144 lists 480 shares dated 02/12/2026 and 631 shares dated 02/14/2026. These figures appear under the securities-to-be-sold entries tied to restricted stock vesting.

Who is the broker handling the transactions in the DGX filing?

The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker. The broker is listed in the securities and routing information for the planned transactions.

Are the DGX shares from sales or vesting events?

The entries are labeled as Restricted Stock Vesting and list the issuer as the source, indicating the shares arise from vesting events and are listed for sale in this notice.

Does the filing show proceeds or pricing for the planned sales?

The provided excerpt does not state sale prices or aggregate proceeds. It lists share counts and dates but does not disclose dollar amounts or execution prices for the transactions.

When were the transactions in DGX's Form 144 dated?

The securities-to-be-sold entries show dates of 02/12/2026 and 02/14/2026, and a form-related date of 02/19/2026 appears in the filing header.
Quest Diagnostics Inc

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Latest SEC Filings

DGX Stock Data

22.32B
109.50M
Diagnostics & Research
Services-medical Laboratories
Link
United States
SECAUCUS